Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Gains from Sales and Divestitures (2010 - 2025)

Updated

Ani Pharmaceuticals (ANIP) posted Gains from Sales and Divestitures of -$87,000 for Q4 2025.

Analysis

Ani Pharmaceuticals (ANIP) Gains from Sales and Divestitures (2010 - 2025) Analysis & Trends

For FY2025, Ani Pharmaceuticals' Gains from Sales and Divestitures came in at -$382,000.

  • In prior years, Ani Pharmaceuticals' Gains from Sales and Divestitures was $5.35 million in FY2024, $750,000 in FY2022 (-58.8%) and $1.82 million in FY2021.
  • The Q4 2025 figure stands as the highest quarterly Gains from Sales and Divestitures since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -87,000.00
Sep 30, 2025 -295,000.00
Mar 31, 2024 5.35 Mn
Dec 31, 2021 1.82 Mn
Mar 31, 2013 1.00 Mn
Dec 31, 2012 -929,431.00
Sep 30, 2012 -117,362.00
Mar 31, 2012 -432.00
Dec 31, 2011 -228.00
Sep 30, 2011 -365,175.00
Mar 31, 2011 -2,099.00
Dec 31, 2010 -5,387.00
API Access

Ani Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ANIP&period=max&api_key=YOUR_API_KEY